Treatment of spent engine oil (spent SAE W50) via solvent extraction- adsorption process for the production of transfer oil: Physico-chemical properties of the adsorbents

Regeneration of base oil from spent engine oil (spent SAE W50) for transfer oil production has been investigated using the solvent extraction-adsorption method. Solvent treated base oil regenerated from spent SAE W50 was treated with activated carbon (AC) from Penthaclatra macophylla pod (PMP) and activated clay (ACL) from Ukpor clay. The oil was characterized before and after treatment for heavy metals content, kinematic viscosity, viscosity index, specific gravity, and pour point. The carbon and clay were characterized using FTIR, BET, SEM-EDX, XRF, and XRD. Characterization results revealed the required properties of the adsorbents that make them capable of adhering impurities to their active sites. Results obtained showed that the optimum conditions for the regeneration of base oil from spent SAE W50 was a temperature of 110 °C, an adsorbent dosage of 5% w/v and a contact time 60 min, with 98% removal of impurities using the mixture of AC and ACL (AC-ACL). The transfer oil was obtained using a blend of the recovered base oil and virgin oil (150 N) at the ratio of 1:1.2. The blend gave the required properties for a transfer oil of similar quality to ISO VG 46

Treatment of spent engine oil (spent SAE W50) via solvent extraction- adsorption process for the production of transfer oil: Physico-chemical properties of the adsorbents

Regeneration of base oil from spent engine oil (spent SAE W50) for transfer oil production has been investigated using the solvent extraction-adsorption method. Solvent treated base oil regenerated from spent SAE W50 was treated with activated carbon (AC) from Penthaclatra macophylla pod (PMP) and activated clay (ACL) from Ukpor clay. The oil was characterized before and after treatment for heavy metals content, kinematic viscosity, viscosity index, specific gravity, and pour point. The carbon and clay were characterized using FTIR, BET, SEM-EDX, XRF, and XRD. Characterization results revealed the required properties of the adsorbents that make them capable of adhering impurities to their active sites. Results obtained showed that the optimum conditions for the regeneration of base oil from spent SAE W50 was a temperature of 110 °C, an adsorbent dosage of 5% w/v and a contact time 60 min, with 98% removal of impurities using the mixture of AC and ACL (AC-ACL). The transfer oil was obtained using a blend of the recovered base oil and virgin oil (150 N) at the ratio of 1:1.2. The blend gave the required properties for a transfer oil of similar quality to ISO VG 46

Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks

Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. It is uncertain whether the PCSK9 example represents a paradigm or an isolated exception. We used the "Exome Array" to genotype >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four low-frequency (frequencies between 0.1% and 2%) variants (ANGPTL8 rs145464906 [c.361C>T; p.Gln121-], PAFAH1B2 rs186808413 [c.482C>T; p.Ser161Leu], COL18A1 rs114139997 [c.331G>A; p.Gly111Arg], and PCSK7 rs142953140 [c.1511G>A; p.Arg504His]) with large effects on HDL-C and/or triglycerides. None of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited

Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

White blood cells play diverse roles in innate and adaptive immunity. Genetic association analyses of phenotypic variation in circulating white blood cell (WBC) counts from large samples of otherwise healthy individuals can provide insights into genes and biologic pathways involved in production, differentiation, or clearance of particular WBC lineages (myeloid, lymphoid) and also potentially inform the genetic basis of autoimmune, allergic, and blood diseases. We performed an exome array-based meta-analysis of total WBC and subtype counts (neutrophils, monocytes, lymphocytes, basophils, and eosinophils) in a multi-ancestry discovery and replication sample of ∼157,622 individuals from 25 studies. We identified 16 common variants (8 of which were coding variants) associated with one or more WBC traits, the majority of which are pleiotropically associated with autoimmune diseases. Based on functional annotation, these loci included genes encoding surface markers of myeloid, lymphoid, or hematopoietic stem cell differentiation (CD69, CD33, CD87), transcription factors regulating lineage specification during hematopoiesis (ASXL1, IRF8, IKZF1, JMJD1C, ETS2-PSMG1), and molecules involved in neutrophil clearance/apoptosis (C10orf54, LTA), adhesion (TNXB), or centrosome and microtubule structure/function (KIF9, TUBD1). Together with recent reports of somatic ASXL1 mutations among individuals with idiopathic cytopenias or clonal hematopoiesis of undetermined significance, the identification of a common regulatory 3′ UTR variant of ASXL1 suggests that both germline and somatic ASXL1 mutations contribute to lower blood counts in otherwise asymptomatic individuals. These association results shed light on genetic mechanisms that regulate circulating WBC counts and suggest a prominent shared genetic architecture with inflammatory and autoimmune diseases

GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes.

Carotid artery intima media thickness (cIMT) and carotid plaque are measures of subclinical atherosclerosis associated with ischemic stroke and coronary heart disease (CHD). Here, we undertake meta-analyses of genome-wide association studies (GWAS) in 71,128 individuals for cIMT, and 48,434 individuals for carotid plaque traits. We identify eight novel susceptibility loci for cIMT, one independent association at the previously-identified PINX1 locus, and one novel locus for carotid plaque. Colocalization analysis with nearby vascular expression quantitative loci (cis-eQTLs) derived from arterial wall and metabolic tissues obtained from patients with CHD identifies candidate genes at two potentially additional loci, ADAMTS9 and LOXL4. LD score regression reveals significant genetic correlations between cIMT and plaque traits, and both cIMT and plaque with CHD, any stroke subtype and ischemic stroke. Our study provides insights into genes and tissue-specific regulatory mechanisms linking atherosclerosis both to its functional genomic origins and its clinical consequences in humans